Shuttle Pharmaceuticals ... (SHPH)
NasdaqCM: SHPH
· Real-Time Price · USD
4.14
-0.17 (-3.94%)
At close: Aug 12, 2026, 1:24 PM
Shuttle Pharmaceuticals Inc. (SHPH) Stock Price, Analysis & Data
-3.94% (1D)
| Bid | 3.12 |
| Market Cap | 2.42M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.82M |
| Beta | 1.22 |
| EPS (ttm) | 0.1 |
| PE Ratio (ttm) | 41.4 |
| Forward PE | n/a |
| P/B (ttm) | 0.69 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 5.49 |
| Volume | 10,326 |
| Avg. Volume (20D) | 2,189,969 |
| Open | 4.33 |
| Previous Close | 4.31 |
| Day's Range | 4.12 - 4.33 |
| 52-Week Range | 2.58 - 55.90 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SHPH
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland....
Sector Healthcare
IPO Date Aug 31, 2022
Employees 2
Stock Exchange NasdaqCM
Ticker Symbol SHPH
Website https://www.shuttlepharma.com
Financial Performance
In 2025, Shuttle Pharmaceuticals's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -11.72M, an increase of 28.18%.
Financial Statements
